This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Explains Devitt: If Im going to extract or source Delta-9 THC from hemp rather than [high-resin] cannabis, Im going to need around 50 times more biomass, which means 50 times more acreage, 50 times more labor, 50 times more water, et cetera, et cetera, [to make a small amount of THC distillate.] Hemp not really hemp Speaking in a Feb.
Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. The cannabis research problem. Despite the massive amount of research publications that come out year over year, many of these studies face one or more research design limitations.
The initiative is part of Project Change Lives; Clever Leaves’ $25M product pledge to aid cannabis research in the U.S. The collaboration represents the Company’s first funded study with a research institution in the United States. organization to help advance scientific research into the potential medical benefits of cannabinoids.
Research Cluster with expert faculty members from various fields, as well as the first and only Drug Dependence Research Center in the country which is certified by the World Health Organization (WHO) Collaborating Center for Research and Training in Drug Dependence. Companies such as Bloom Medica Co.,
After over four years of observation, the researchers found no traces of Chronic Obstructive Pulmonary Disease (COPD) —a condition commonly associated with tobacco smoking, characterized by coughing and shortness of breath—whether in developmental or advanced stages.
This issue is compounded when veterans do, on rare occasions, ask their doctors about medical marijuana, only to be treated as if they are mentally unstable or receive no specific health information at all,” the researchers found. This directly conflicts with past research claiming marijuana increases PTSD symptom severity.”.
The new Radicle Science-OBX alliance fills an unmet need for rigorous scientific research in the cannabis industry and sets a new gold standard for CBD and minor cannabinoid product development.
CSE: MXT) (OTCQB: MXTTF) is known for its award-winning extraction equipment, but recently, the company refocused its efforts on its proprietary health-related databases, machine learning analysis, and plans to engage in B2B licensing and mHealth. Data Bridge Market Research believes that psychedelics will grow at a 13.3%
2021 /CNW/ – Halo Collective Inc. (“Halo”) (NEO: HALO) (OTCQX: HCANF) (Germany: A9KN), a vertically integrated multinational cannabis company, today announced that its board of directors has unanimously approved the reorganization (the “International Reorganization”) of its non-U.S. TORONTO , June 22,?2021
A major component of the program will be the development of new ways to infuse both the psychedelic compounds and fungi components into products to both improve bioavailability and to mask the bitter tastes of the fungus and its components.
The Pharmaceutical Organization, Department of Medical Affairs, signed a joint research on standard quality medical marijuana extracts for patients with chemo-allergic cancer, epilepsy, muscle contraction in patients with deteriorating nerve sheaths. Today (30 May) at 09.30 Effective, most effective in treatment Relieve symptoms.
Researchers Inspected Cannabis Products for Contaminants. Dr. Maxwell’s team also collected data contained in samples sourced from California. There was more inconsistency in cannabis-borne contaminant regulation as compared with other agricultural commodities,” wrote the researchers. for extracts.
The Phoenix-based cannabis brand has been building its cannabis selection since 2012 when it began researching and cultivating various strains for medical use. Kind Meds offers a rotating variety of strains developed by AZ Nectar Farms on our fresh menu. About AZ Nectar Farms. Here are two of the most popular: Strain: GG #4.
Now, psychedelic research is booming. And while most psychedelics are currently illegal in the United States and around the world, researchers are exploring their use in medicine to treat conditions such as depression, PTSD, addiction, anxiety, OCD, migraines, end of life acceptance of mortality, and eating disorders. 19 20 21 22 23.
Reviews, selects, evaluates and consolidates incoming intelligence data and related information and insures that follow-up actions are initiated; collects additional data to fill gaps; disseminates action items to the responsible enforcement entities.
This was the time when the country approved the sales of edibles, cannabis extracts, and topicals. The increased number of brick and mortar and click and collect offerings brought upon by expanding online cannabis space helped boost sales. . By this, they meant what they think about selling, labeling, and researching cannabis.
to provide naturally derived psilocybin for research and development of therapeutic products. “As the research and drug development work on psilocybin moves forward, HAVN Life continues to position itself as a supply chain leader, able to meet the demand for naturally derived psilocybin,” he adds.
The company benefits from a 365-day cultivation window and has developed proprietary hemp strains tailored for the region alongside state-of-the-art processing and extraction facilities. The Agronomic Research and Data Collectionresearch program is designed to optimize quality and yield of hemp grown in the Imperial Valley. .
Customer to use PharmaCielo’s CBD Isolate for expanded research and development of an innovative sublingual product platform. The Customer intends to use PharmaCielo’s Active Pharmaceutical Ingredients (APIs) for expanded research and development of their innovative, proprietary sublingual product platform.
Designed for developing and entrepreneurial companies in the United States and abroad, companies must be current in their financial reporting and undergo an annual verification and management certification process, including meeting a minimum bid price and other financial conditions. Securities and Exchange Commission. Web: [link].
But as the pharmaceutical use is becoming more and more popular internationally, the province is also keen on developing the pharmaceutical sector. The government is also seeking cooperation partners on CBD extraction in Europe and North America by offering them an excellent infrastructure and investment subsidies.
Products will be distributed through Valens’ Australian Distribution Partner, Cannvalate PTY Ltd (“Cannvalate”), and will be the largest quantity of products provided to Cannvalate for distribution to date (collectively, the “ Transaction “).
It’s interesting that something like CBD isolate should be enhanced given how much time and energy has been put into developingextraction techniques that even let us arrive at CBD isolate in the first place. One necessary byproduct of the CBD or even THC extraction process is terpenes. Enhancing CBD isolate with terpenes.
With the interest in potential utility of cannabis to develop treatments for a variety of medical conditions and the continued issuance of cannabis patents, the number of cannabis patent proceedings is likely to increase as well. Pure Hemp Collective, Inc. GW Pharma Limited and GW Research Limited , Case No. 1:18-cv-01922 (D.
The laboratory researched the fine print of every state’s rules for hemp sampling, THC potency, cannabinoid content, residual solvents, pesticides, mycotoxins, heavy metals, and microbiology. With that research, they created elaborate matrices to compare each mandate. Source: [link].
Hemp Acres has built 3 facilities specialized for each hemp commodity, totaling 40,000 sq ft of food grade hemp processing facilities, designed to handle 50,000 acres of contracted hemp throughout the midwest for grain, fiber, and botanical extracts. Smith owns and operates a Minnesota-based CBD extraction facility.
21, 2019 (GLOBE NEWSWIRE) — Clever Leaves , a leading vertically-integrated licensed producer of pharmaceutical-grade medical cannabis and hemp extracts, has received a pre-license letter from INFARMED I.P., Clever Leaves’ facility is being developed on 85 hectares of land. NEW YORK, Nov. About Clever Leaves.
This would make the first Cannabis genome reference that reflects a living plant where a researcher could acquire a cutting or a seed of the plant. Ampure is used as the final step after a chloroform extraction. MGC SenSATIVAx® MIP/Extract Protocol for PathoSEEK® Robotic DNA purification was performed on sterilized mature stalks.
commented “After extensive research of global suppliers we are proud to partner with LUFF. Alkannoli’s executive team boasts current and previous success in FMCG, Retail, Pharma and international business development, we are excited to align with Philip and the LUFF team to establish and grow the Portuguese and German markets.
Each gummy is packed with 10mg of CV Sciences’ award-winning full spectrum hemp extract CBD, L-Theanine and 5-HTP for positive mood support and mental relaxation without feeling impaired. . It’s infused with arnica extract, which has been said to treat everything from inflammation, bruising and swelling to sprains and severe muscle tension.
BPH Energy (ASX: BPH) has announced that its investee company Patagonia Genetics has acquired an additional 24 cannabidiol (CBD) and hemp strains to add to its existing collection of over 260 strains, thereby expanding and expediting its plans to commercialise its overall genetic library next year. Bountiful hemp industry progress.
Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. Validcare contracted with 17 CBD companies and acted as the Contract Research Organization, which included gaining feedback from FDA on the protocol, conducting the study and publishing its results.
For example, research shows that primary care physicians misdiagnosed 65.9% Researchers are just starting to uncover the potential for psychedelics to treat mental health disorders. Investors may want to take a closer look at the stock as it continues to collect complete reference records ahead of its launch late this year.
Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. Validcare contracted with 17 CBD companies and acted as the Contract Research Organization, which included gaining feedback from FDA on the protocol, conducting the study and publishing its results.
Curaleaf International is the leading vertically integrated cannabis company in Europe with a unique supply and distribution network throughout the European market, bringing together pioneering science and research with cutting-edge cultivation, extraction, and production. Home | Curaleaf | Cannabis with Confidence.
Five Best CBD Capsules Most Pure Products: Royal CBD Softgel Capsules Highlights: -25mg CBD per capsule -Full-spectrum CBD capsules -Third-party lab tested and approved Royal CBD uses a CO2 extraction process to make full-spectrum CBD products from organic, American-grown hemp. Many CBD enthusiasts take up to 50mg a day.)
Construction of New Melbourne-area Extraction Facility on Schedule. TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, distillation, purification and cannabinoid isolation, is pleased to announce that its subsidiary MediPharm Labs Australia Pty. (TSX:
On the topic of sustainability, Florida also currently lacks a dedicated patient or clinic “cannabis collection” station for used cannabis products; an integrated program for safe disposal here in Florida must be addressed, by the Medical Marijuana Advisory Committee or other dedicated state body. .
(NASDAQ: FLGC) (“Flora” or the “Company”), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, announced today the appointment of operations and personnel development expert, Joël Reyes as Senior Vice President of Global Operations. About Flora Growth Corp.
to my knowledge, there are no state-governed collection programs built into medical cannabis policy, compliance, legal or tax frameworks, or end user means of disposal. Further development and industrialisation of alternative tecnologies will enable the industry to deliver zero-waste turbines.” We can always hope. In the U.S.,
Designed for developing and entrepreneurial companies in the United States and abroad, companies must be current in their financial reporting and undergo an annual verification and management certification process, including meeting a minimum bid price and other financial conditions. Securities and Exchange Commission. Web: [link].
ESENIA is intended to be Clever Leaves’ premium hemp oil brand and part of a larger commercial line of wellness products that is being developed from high-quality Colombian hemp. Clever Leaves is a vertically-integrated Colombian company and legally licensed to cultivate and extract hemp and medicinal cannabis.
The establishment of the genetics and cultivation advisor role comes as Flora ramps up cannabis production, including its recently completed EU-GMP compliant extraction lab. He previously oversaw WeedMD’s Canadian cultivation development and design as Chief Cannabis Officer, installing one of Canada’s first successful legal outdoor grows.
Alongside the Core Business, we remain agile and innovative, developing new solutions to fight the pandemic. The following figures are extracts from the Condensed Interim Consolidated Financial Statements and should be read in conjunction with the Condensed Interim Consolidated Financial Statements and Notes for the period ended 30 June 2021.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content